Caricamento...
Cellular Immune Response to an Engineered Cell-Based Tumor Vaccine at the Vaccination Site
The engineered expression of the immune co-stimulatory molecules CD80 and CD137L on the surface of a neuroblastoma cell line converts this tumor into a cell-based cancer vaccine. The mechanism by which this vaccine activates the immune system was investigated by capturing and analyzing immune cells...
Salvato in:
Autori principali: | , , |
---|---|
Natura: | Artigo |
Lingua: | Inglês |
Pubblicazione: |
2007
|
Soggetti: | |
Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1949498/ https://ncbi.nlm.nih.gov/pubmed/17543914 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cellimm.2007.04.004 |
Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|